glp-1 news november 3 2025 ISPOR 2025: Exploring reasons for GLP-1 discontinuation GLP-1 Weight-Loss Drugs Could Address

Description

Despite currently holding a smaller share, this steady increase has been paired with government support, with the most recent support consisting of a program where general practitioners receive monetary bonuses from the government for prescribing a GLP-1 treatment plan for weight loss patients

For tirzepatide users, constipation management , diarrhea duration , and fatigue follow similar patterns

Many of the self-pay options connect patients with doctors on telehealth who will determine if they qualify for the drugs and write a prescription

Moving from retatrutide to a moderate dose of semaglutide or tirzepatide can provide ongoing appetite suppression at a lower cost point

Ingredient transparency, realistic claims, clear refund policies, disclosed corporate information, and absence of language implying equivalence to prescription medications